150 related articles for article (PubMed ID: 37401100)
1. Differences in patient-reported outcomes (PROs) by disease severity in light chain (AL) amyloidosis.
D'Souza A; Szabo A; Akinola I; Finkel M; Flynn KE
Eur J Haematol; 2023 Oct; 111(4):536-543. PubMed ID: 37401100
[TBL] [Abstract][Full Text] [Related]
2. The use of PROMIS patient-reported outcomes (PROs) to inform light chain (AL) amyloid disease severity at diagnosis.
D'Souza A; Magnus BE; Myers J; Dispenzieri A; Flynn KE
Amyloid; 2020 Jun; 27(2):111-118. PubMed ID: 31971467
[TBL] [Abstract][Full Text] [Related]
3. Development and initial validation of the AL-PROfile patient-reported outcome measure in light chain (AL) amyloidosis.
D'Souza A; Szabo A; Akinola I; Finkel M; Flynn KE
Eur J Haematol; 2024 Jun; 112(6):900-909. PubMed ID: 38350661
[TBL] [Abstract][Full Text] [Related]
4. Changes in patient-reported outcomes in light chain amyloidosis in the first year after diagnosis and relationship to NT-proBNP change.
D'Souza A; Brazauskas R; Dispenzieri A; Panepinto J; Flynn KE
Blood Cancer J; 2021 Feb; 11(2):29. PubMed ID: 33563897
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study of patient-reported outcomes and symptom burden using PROMIS and PRO-CTCAE measures in light chain amyloidosis.
D'Souza A; Szabo A; Akinola I; Finkel M; Flynn KE
Qual Life Res; 2023 Jun; 32(6):1807-1817. PubMed ID: 36738402
[TBL] [Abstract][Full Text] [Related]
6. Association between PROMIS10, SF-36 and NeuroQoL in persons with multiple sclerosis.
Healy BC; Liu Y; Winston-Khan S; Weiner HL; Chitnis T; Glanz BI
Mult Scler Relat Disord; 2023 Nov; 79():105003. PubMed ID: 37741027
[TBL] [Abstract][Full Text] [Related]
7. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ
Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported outcomes in systemic AL amyloidosis with functional assessment of cancer therapy-general (FACT-G) and patient-reported outcomes measurement information system-global health (PROMIS-GH) in a real-world population.
Chakraborty R; Rybicki L; Tomer J; Samaras CJ; Faiman BM; Valent J; Majhail NS
Leuk Lymphoma; 2019 Dec; 60(14):3544-3551. PubMed ID: 31272258
[TBL] [Abstract][Full Text] [Related]
9. Which NDI domains best predict change in physical function in patients undergoing cervical spine surgery?
Steinhaus ME; Iyer S; Lovecchio F; Stein D; Ross T; Yang J; Lafage V; Albert TJ; Kim HJ
Spine J; 2019 Oct; 19(10):1698-1705. PubMed ID: 31207316
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Concurrent Validity of PROMIS Physical Function in Anterior Cervical Discectomy and Fusion.
Khechen B; Patel DV; Haws BE; Cardinal KL; Guntin JA; Ahn J; Singh K
Clin Spine Surg; 2019 Dec; 32(10):449-453. PubMed ID: 30730428
[TBL] [Abstract][Full Text] [Related]
11. Psychometric Evaluation of the Patient-Reported Outcomes Measurement Information System Fatigue-Short Form Across Diverse Populations.
Ameringer S; Elswick RK; Menzies V; Robins JL; Starkweather A; Walter J; Gentry AE; Jallo N
Nurs Res; 2016; 65(4):279-89. PubMed ID: 27362514
[TBL] [Abstract][Full Text] [Related]
12. The sensitivity of the MOS SF-12 and PROMIS® global summary scores to adverse health events in an older cohort.
Allen J; Alpass FM; Stephens CV
Qual Life Res; 2018 Aug; 27(8):2207-2215. PubMed ID: 29725968
[TBL] [Abstract][Full Text] [Related]
13. The Relationship Among 3 Generic Patient-Reported Outcome Instruments in Patients With Lower Extremity Health Conditions.
Hoch JM; Lorete C; Legner J; Hoch MC
J Athl Train; 2019 May; 54(5):550-555. PubMed ID: 31084504
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis.
Tomasson G; Farrar JT; Cuthbertson D; McAlear CA; Ashdown S; Cronholm PF; Dawson J; Gebhart D; Lanier G; Luqmani RA; Milman N; Peck J; Robson JC; Shea JA; Carette S; Khalidi N; Koening CL; Langford CA; Monach PA; Moreland L; Pagnoux C; Specks U; Sreih AG; Ytterberg SR; Merkel PA;
J Rheumatol; 2019 Aug; 46(8):928-934. PubMed ID: 30824648
[TBL] [Abstract][Full Text] [Related]
15. Validation of PROMIS Physical Function in MIS TLIF: 2-Year Follow-up.
Jenkins NW; Parrish JM; Cha EDK; Lynch CP; Sayari AJ; Geoghegan CE; Jadczak CN; Mohan S; Singh K
Spine (Phila Pa 1976); 2020 Nov; 45(22):E1516-E1522. PubMed ID: 32756287
[TBL] [Abstract][Full Text] [Related]
16. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus.
Azizoddin DR; Weinberg S; Gandhi N; Arora S; Block JA; Sequeira W; Jolly M
Lupus; 2018 Apr; 27(5):728-737. PubMed ID: 29087259
[TBL] [Abstract][Full Text] [Related]
17. Correlation between NDI, PROMIS and SF-12 in cervical spine surgery.
Vaishnav AS; Gang CH; Iyer S; McAnany S; Albert T; Qureshi SA
Spine J; 2020 Mar; 20(3):409-416. PubMed ID: 31678044
[TBL] [Abstract][Full Text] [Related]
18. PROMIS: a valid and efficient outcomes instrument for patients with ACL tears.
Hancock KJ; Glass N; Anthony CA; Wolf BR; Hettrich CM; Albright J; Bollier M; Amendola A
Knee Surg Sports Traumatol Arthrosc; 2019 Jan; 27(1):100-104. PubMed ID: 29974172
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life of patients with cystic fibrosis assessed by the SF-36 questionnaire.
Uchmanowicz I; Jankowska-Polańska B; Wleklik M; Rosinczuk-Tonderys J; Dębska G
Pneumonol Alergol Pol; 2014; 82(1):10-7. PubMed ID: 24391066
[TBL] [Abstract][Full Text] [Related]
20. Weightbearing and Activity Restriction Treatments and Quality of Life in Patients with Perthes Disease.
Do DH; McGuire MF; Jo CH; Kim HKW
Clin Orthop Relat Res; 2021 Jun; 479(6):1360-1370. PubMed ID: 33394755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
